Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1: Structure-activity analysis

Sarvesh Kumar, Chandra Shekhar Reddy L, Yogesh Kumar, Amit Kumar, Brajendra K. Singh, Vineet Kumar, Shashwat Malhotra, Mukesh Pandey, Rajni Jain, Rajesh Thimmulappa, Sunil K. Sharma, Ashok K. Prasad, Shyam Biswal, Erik Van Der Eycken, Anthony L. Depass, Sanjay V. Malhotra, Balaram Ghosh, Virinder S. Parmar

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The interaction between leukocytes and the vascular endothelial cells (EC) via cellular adhesion molecules plays an important role in the pathogenesis of various inflammatory and autoimmune diseases. Small molecules that block these interactions have been targeted as potential therapeutic agents against acute and chronic inflammatory diseases. In an effort to identify potent intercellular cell adhesion molecule-1 (ICAM-1) inhibitors, a large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones and their analogs (54 in total) have been synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated the possible mechanism for their ICAM-1 inhibitory activities. The most active compound was found to be 79. A large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones as well as their analogs (54 in total) were synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated a possible mechanism of their ICAM-1 inhibitory activities. The most active compound was found to be 79.

Original languageEnglish (US)
Pages (from-to)368-377
Number of pages10
JournalArchiv der Pharmazie
Volume345
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

Benzophenones
Chalcones
Cell Adhesion Molecules
Intercellular Adhesion Molecule-1
Ketones
Chalcone
Structure-Activity Relationship
Autoimmune Diseases
Leukocytes
Chronic Disease
Endothelial Cells

Keywords

  • Arylalkyl ketones
  • Benzophenones
  • Chalcones
  • Desoxybenzoins
  • Endothelial cells
  • ICAM-1

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery

Cite this

Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1 : Structure-activity analysis. / Kumar, Sarvesh; Reddy L, Chandra Shekhar; Kumar, Yogesh; Kumar, Amit; Singh, Brajendra K.; Kumar, Vineet; Malhotra, Shashwat; Pandey, Mukesh; Jain, Rajni; Thimmulappa, Rajesh; Sharma, Sunil K.; Prasad, Ashok K.; Biswal, Shyam; Van Der Eycken, Erik; Depass, Anthony L.; Malhotra, Sanjay V.; Ghosh, Balaram; Parmar, Virinder S.

In: Archiv der Pharmazie, Vol. 345, No. 5, 01.05.2012, p. 368-377.

Research output: Contribution to journalArticle

Kumar, S, Reddy L, CS, Kumar, Y, Kumar, A, Singh, BK, Kumar, V, Malhotra, S, Pandey, M, Jain, R, Thimmulappa, R, Sharma, SK, Prasad, AK, Biswal, S, Van Der Eycken, E, Depass, AL, Malhotra, SV, Ghosh, B & Parmar, VS 2012, 'Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1: Structure-activity analysis', Archiv der Pharmazie, vol. 345, no. 5, pp. 368-377. https://doi.org/10.1002/ardp.201100279
Kumar, Sarvesh ; Reddy L, Chandra Shekhar ; Kumar, Yogesh ; Kumar, Amit ; Singh, Brajendra K. ; Kumar, Vineet ; Malhotra, Shashwat ; Pandey, Mukesh ; Jain, Rajni ; Thimmulappa, Rajesh ; Sharma, Sunil K. ; Prasad, Ashok K. ; Biswal, Shyam ; Van Der Eycken, Erik ; Depass, Anthony L. ; Malhotra, Sanjay V. ; Ghosh, Balaram ; Parmar, Virinder S. / Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1 : Structure-activity analysis. In: Archiv der Pharmazie. 2012 ; Vol. 345, No. 5. pp. 368-377.
@article{42c9fee5c62f49babc42b921221cc226,
title = "Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1: Structure-activity analysis",
abstract = "The interaction between leukocytes and the vascular endothelial cells (EC) via cellular adhesion molecules plays an important role in the pathogenesis of various inflammatory and autoimmune diseases. Small molecules that block these interactions have been targeted as potential therapeutic agents against acute and chronic inflammatory diseases. In an effort to identify potent intercellular cell adhesion molecule-1 (ICAM-1) inhibitors, a large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones and their analogs (54 in total) have been synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated the possible mechanism for their ICAM-1 inhibitory activities. The most active compound was found to be 79. A large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones as well as their analogs (54 in total) were synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated a possible mechanism of their ICAM-1 inhibitory activities. The most active compound was found to be 79.",
keywords = "Arylalkyl ketones, Benzophenones, Chalcones, Desoxybenzoins, Endothelial cells, ICAM-1",
author = "Sarvesh Kumar and {Reddy L}, {Chandra Shekhar} and Yogesh Kumar and Amit Kumar and Singh, {Brajendra K.} and Vineet Kumar and Shashwat Malhotra and Mukesh Pandey and Rajni Jain and Rajesh Thimmulappa and Sharma, {Sunil K.} and Prasad, {Ashok K.} and Shyam Biswal and {Van Der Eycken}, Erik and Depass, {Anthony L.} and Malhotra, {Sanjay V.} and Balaram Ghosh and Parmar, {Virinder S.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1002/ardp.201100279",
language = "English (US)",
volume = "345",
pages = "368--377",
journal = "Archiv der Pharmazie",
issn = "0365-6233",
publisher = "Wiley-VCH Verlag",
number = "5",

}

TY - JOUR

T1 - Arylalkyl ketones, benzophenones, desoxybenzoins and chalcones inhibit TNF-α induced expression of ICAM-1

T2 - Structure-activity analysis

AU - Kumar, Sarvesh

AU - Reddy L, Chandra Shekhar

AU - Kumar, Yogesh

AU - Kumar, Amit

AU - Singh, Brajendra K.

AU - Kumar, Vineet

AU - Malhotra, Shashwat

AU - Pandey, Mukesh

AU - Jain, Rajni

AU - Thimmulappa, Rajesh

AU - Sharma, Sunil K.

AU - Prasad, Ashok K.

AU - Biswal, Shyam

AU - Van Der Eycken, Erik

AU - Depass, Anthony L.

AU - Malhotra, Sanjay V.

AU - Ghosh, Balaram

AU - Parmar, Virinder S.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - The interaction between leukocytes and the vascular endothelial cells (EC) via cellular adhesion molecules plays an important role in the pathogenesis of various inflammatory and autoimmune diseases. Small molecules that block these interactions have been targeted as potential therapeutic agents against acute and chronic inflammatory diseases. In an effort to identify potent intercellular cell adhesion molecule-1 (ICAM-1) inhibitors, a large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones and their analogs (54 in total) have been synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated the possible mechanism for their ICAM-1 inhibitory activities. The most active compound was found to be 79. A large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones as well as their analogs (54 in total) were synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated a possible mechanism of their ICAM-1 inhibitory activities. The most active compound was found to be 79.

AB - The interaction between leukocytes and the vascular endothelial cells (EC) via cellular adhesion molecules plays an important role in the pathogenesis of various inflammatory and autoimmune diseases. Small molecules that block these interactions have been targeted as potential therapeutic agents against acute and chronic inflammatory diseases. In an effort to identify potent intercellular cell adhesion molecule-1 (ICAM-1) inhibitors, a large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones and their analogs (54 in total) have been synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated the possible mechanism for their ICAM-1 inhibitory activities. The most active compound was found to be 79. A large number of arylalkyl ketones, benzophenones, desoxybenzoins and chalcones as well as their analogs (54 in total) were synthesized and screened for their ICAM-1 inhibitory activity. The structure-activity relationship studies of these compounds identified three potent chalcone derivatives and also demonstrated a possible mechanism of their ICAM-1 inhibitory activities. The most active compound was found to be 79.

KW - Arylalkyl ketones

KW - Benzophenones

KW - Chalcones

KW - Desoxybenzoins

KW - Endothelial cells

KW - ICAM-1

UR - http://www.scopus.com/inward/record.url?scp=84861325220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861325220&partnerID=8YFLogxK

U2 - 10.1002/ardp.201100279

DO - 10.1002/ardp.201100279

M3 - Article

C2 - 22190402

AN - SCOPUS:84861325220

VL - 345

SP - 368

EP - 377

JO - Archiv der Pharmazie

JF - Archiv der Pharmazie

SN - 0365-6233

IS - 5

ER -